ThermoGenesis Holdings, Inc. (THMO)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Jun 30, 2017	Jun 30, 2016
Device- Automated Cell Separation System	4.97M
Device- Automated Cell Separation System Growth	-15.92%
Device- Automated Cryopreservation System	1.48M
Device- Automated Cryopreservation System Growth	19.01%
Service- Automated Cryopreservation System	1.36M
Service- Automated Cryopreservation System Growth	40.60%
Other- X-Series	779.00K
Other- X-Series Growth	173.33%
Device- Other	288.00K
Device- Other Growth	350.00%
Service- Automated Cell Separation System	232.00K
Service- Automated Cell Separation System Growth	-51.67%
Service- X-Series	152.00K
Service- X-Series Growth	-20.00%
Device- X-Series	121.00K
Device- X-Series Growth	-81.50%
Other	58.00K
Other Growth	100.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Jun 30, 2017	Jun 30, 2016
United States	6.03M
United States Growth	-9.22%
United Arab Emirates	570.00K
Vietnam	225.00K
Vietnam Growth	-56.31%
China	98.00K
China Growth	-95.06%
Other	2.52M
Other Growth	216.17%